LAMEA Microbial Fermentation Technology Market

LAMEA Microbial Fermentation Technology Market Size, Share & Industry Trends Analysis Report By Application, By End User (CMOs & CDMOs, Bio-Pharmaceutical Companies, Contract Research Organizations (CROs) and Others), By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-14539 Publication Date: March-2023 Number of Pages: 84
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Microbial Fermentation Technology Market, by Application
1.4.2 LAMEA Microbial Fermentation Technology Market, by End User
1.4.3 LAMEA Microbial Fermentation Technology Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Microbial Fermentation Technology Market
Chapter 4. LAMEA Microbial Fermentation Technology Market by Application
4.1 LAMEA Antibiotics Market by Country
4.2 LAMEA Recombinant Proteins Market by Country
4.3 LAMEA Enzymes Market by Country
4.4 LAMEA Monoclonal Antibodies Market by Country
4.5 LAMEA Probiotics Supplements Market by Country
4.6 LAMEA Vaccines Market by Country
4.7 LAMEA Biosimilars Market by Country
4.8 LAMEA Small Molecules Market by Country
4.9 LAMEA Others Market by Country

Chapter 5. LAMEA Microbial Fermentation Technology Market by End-user
5.1 LAMEA CMOs & CDMOs Market by Country
5.2 LAMEA Bio-Pharmaceutical Companies Market by Country
5.3 LAMEA Contract Research Organizations (CROs) Market by Country
5.4 LAMEA Others Market by Country

Chapter 6. LAMEA Microbial Fermentation Technology Market by Country
6.1 Brazil Microbial Fermentation Technology Market
6.1.1 Brazil Microbial Fermentation Technology Market by Application
6.1.2 Brazil Microbial Fermentation Technology Market by End-user
6.2 Argentina Microbial Fermentation Technology Market
6.2.1 Argentina Microbial Fermentation Technology Market by Application
6.2.2 Argentina Microbial Fermentation Technology Market by End-user
6.3 UAE Microbial Fermentation Technology Market
6.3.1 UAE Microbial Fermentation Technology Market by Application
6.3.2 UAE Microbial Fermentation Technology Market by End-user
6.4 Saudi Arabia Microbial Fermentation Technology Market
6.4.1 Saudi Arabia Microbial Fermentation Technology Market by Application
6.4.2 Saudi Arabia Microbial Fermentation Technology Market by End-user
6.5 South Africa Microbial Fermentation Technology Market
6.5.1 South Africa Microbial Fermentation Technology Market by Application
6.5.2 South Africa Microbial Fermentation Technology Market by End-user
6.6 Nigeria Microbial Fermentation Technology Market
6.6.1 Nigeria Microbial Fermentation Technology Market by Application
6.6.2 Nigeria Microbial Fermentation Technology Market by End-user
6.7 Rest of LAMEA Microbial Fermentation Technology Market
6.7.1 Rest of LAMEA Microbial Fermentation Technology Market by Application
6.7.2 Rest of LAMEA Microbial Fermentation Technology Market by End-user

Chapter 7. Company Profiles
7.1 Biocon Limited
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisition and Mergers:
7.2 BioVectra Inc. (H.I.G. Capital, LLC)
7.2.1 Company Overview
7.2.2 Recent strategies and developments:
7.2.2.1 Partnerships, Collaborations, and Agreements:
7.2.2.2 Product Launches and Product Expansions:
7.2.2.3 Geographical Expansions:
7.3 Danone S.A.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Category and Regional Analysis
7.3.4 Recent strategies and developments:
7.3.4.1 Geographical Expansions:
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Koninklijke DSM N.V.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition, Joint Venture and Mergers:
7.6 Lonza Group AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 Novozymes A/S (Novo Holdings A/S)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Product Launches and Product Expansions:
7.8 Corbion N.V.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Bangalore Biotech Labs Pvt. Ltd. (BiOZEEN)
7.9.1 Company Overview
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo